2024 STS Coronary Conference Session 1: Conduit Selection

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Mario F. L. Gaudino, MD, PhD
Disclosure(s): Abbott Vascular: Consultant/Advisory Board

Elaine E. Tseng, MD
Disclosure(s): Amgen Inc, Portrero Med Inc, Cellphire Inc: Research Grant

Presentations

  1. Who Benefits From the RITA as a Second Conduit?
    Joseph F. Sabik III, MD
    Disclosure(s): Medtronic: Consultant/Advisory Board
     
  2. Should All Patients Have a Radial Artery Graft?
    James Tatoulis, MD, MBBS, MS
     
  3. Which Patient Should Only Recieve LITA and Veins?
    Ki-Bong Kim, MD
     
  4. Who is the Ideal TAR Patient? 
    Massimo G. Lemma, MD
     
  5. Is My Conduit Selection Different When the Patient Is a Woman?
    Rashmi Yadav, MBBS
    Disclosure(s): NeiChord: Surgical Proctor; Medtronic: Consultant/Advisory Board
     
  6. Panel Discussion
Activity summary
Available credit: 
  • 1.25 ABS Accredited CME
  • 1.25 ABTS Accredited CME
  • 1.25 AMA PRA Category 1 Credit
  • 1.25 Participation
Activity opens: 
06/21/2024
Activity expires: 
06/30/2025
Cost:
$0.00
Rating: 
3

Available Credit

  • 1.25 ABS Accredited CME
  • 1.25 ABTS Accredited CME
  • 1.25 AMA PRA Category 1 Credit
  • 1.25 Participation

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Mario F. L. Gaudino, MD, PhD
Disclosure(s): Abbott Vascular: Consultant/Advisory Board

Elaine E. Tseng, MD
Disclosure(s): Amgen Inc, Portrero Med Inc, Cellphire Inc: Research Grant

Presentations

  1. Who Benefits From the RITA as a Second Conduit?
    Joseph F. Sabik III, MD
    Disclosure(s): Medtronic: Consultant/Advisory Board
     
  2. Should All Patients Have a Radial Artery Graft?
    James Tatoulis, MD, MBBS, MS
     
  3. Which Patient Should Only Recieve LITA and Veins?
    Ki-Bong Kim, MD
     
  4. Who is the Ideal TAR Patient? 
    Massimo G. Lemma, MD
     
  5. Is My Conduit Selection Different When the Patient Is a Woman?
    Rashmi Yadav, MD
    Disclosure(s): NeiChord: Surgical Proctor; Medtronic: Consultant/Advisory Board
     
  6. Panel Discussion